Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelomonocytic, Chronic × talazoparib × 90 days × Clear all

Sponsor

Conditions

Neoplasm Metastasis 5 Breast Neoplasms 5 Prostatic Neoplasms 4 Neoplasms 4 Ovarian Neoplasms 2 mCRPC 1 Wilms Tumor 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Leukemia 1 Hepatoblastoma 1 Hemangiosarcoma 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1

Interventions

Azacitidine 14 venetoclax 12 Specimen Handling 7 Decitabine 7 Biopsy 7 fludarabine 6 Injections 6 decitabine and cedazuridine drug combination 5 Stem Cell Transplantation 5 Cytarabine 5 Cyclophosphamide 5 fludarabine phosphate 4 Whole-Body Irradiation 4 Tacrolimus 3 Mycophenolic Acid 3 Hematopoietic Stem Cell Transplantation 3 Busulfan 3 sabatolimab 2 ruxolitinib 2 olutasidenib 2 enasidenib 2 cedazuridine 2 axatilimab 2 X-Rays 2 Vorinostat 2 Peripheral Blood Stem Cell Transplantation 2 Magnetic Resonance Spectroscopy 2 Lenalidomide 2 Idarubicin 2 Granulocyte Colony-Stimulating Factor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡